PPAT and posterior cortical atrophy: In conclusion, this study provides preliminary evidence that the secretome of obesogen-dysregulated PPAT can significantly enhance the viability of prostate cells and may have a role in PCa resistance to taxane-based chemotherapy (specifically docetaxel and cabazitaxel).